Videos Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Investors are learning that paying 20X sales is nothing if the growth numbers are right. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook Stock-market investors cheered end of election uncertainty. Policy uncertainty remains. Snowflake’s stock flies higher as software company’s outlook impresses Autonomous Vehicles: Why 2025 Will Usher in the Self-Driving Car Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits